Verastem (VSTM) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Verastem Revenue Highlights

Latest Revenue (Y)

$30.91M

Latest Revenue (Q)

$11.24M

Main Segment (Y)

Government rebates and other incentives

Verastem Revenue by Period

Verastem Revenue by Year

Date	Revenue	Change
2025-12-31	$30.91M	209.14%
2024-12-31	$10.00M	100.00%
2023-12-31	-	-100.00%
2022-12-31	$2.60M	26.45%
2021-12-31	$2.05M	-97.68%
2020-12-31	$88.52M	407.08%
2019-12-31	$17.46M	-34.67%
2018-12-31	$26.72M	100.00%
2017-12-31	-	100.00%
2016-12-31	-	100.00%
2015-12-31	-	100.00%
2014-12-31	-	100.00%
2013-12-31	-	100.00%
2012-12-31	-	100.00%
2011-12-31	-	100.00%
2010-12-31	-	-

Verastem generated $30.91M in revenue during NA 2025, up 209.14% compared to the previous quarter, and up 34.92% compared to the same period a year ago.

Verastem Revenue by Quarter

Date	Revenue	Change
2025-09-30	$11.24M	426.06%
2025-06-30	$2.14M	100.00%
2025-03-31	-	-100.00%
2024-12-31	$-9.98M	100.00%
2024-09-30	-	-100.00%
2024-06-30	$10.00M	100.00%
2024-03-31	-	-100.00%
2023-12-31	$114.00K	100.00%
2023-09-30	-	100.00%
2023-06-30	-	100.00%
2023-03-31	-	-100.00%
2022-12-31	$2.60M	100.00%
2022-09-30	-	100.00%
2022-06-30	-	-100.00%
2022-03-31	$2.60M	376.33%
2021-12-31	$545.00K	27150.00%
2021-09-30	$2.00K	-99.60%
2021-06-30	$500.00K	-50.30%
2021-03-31	$1.01M	98.81%
2020-12-31	$506.00K	-99.36%
2020-09-30	$78.65M	1726.03%
2020-06-30	$4.31M	-14.81%
2020-03-31	$5.06M	39.82%
2019-12-31	$3.62M	-59.96%
2019-09-30	$9.03M	188.01%
2019-06-30	$3.14M	87.67%
2019-03-31	$1.67M	38.10%
2018-12-31	$1.21M	-92.20%
2018-09-30	$15.51M	55.08%
2018-06-30	$10.00M	100.00%
2018-03-31	-	100.00%
2017-12-31	-	100.00%
2017-09-30	-	100.00%
2017-06-30	-	100.00%
2017-03-31	-	100.00%
2016-12-31	-	100.00%
2016-09-30	-	100.00%
2016-06-30	-	100.00%
2016-03-31	-	100.00%
2015-12-31	-	100.00%
2015-09-30	-	100.00%
2015-06-30	-	100.00%
2015-03-31	-	100.00%
2014-12-31	-	100.00%
2014-09-30	-	100.00%
2014-06-30	-	100.00%
2014-03-31	-	100.00%
2013-12-31	-	100.00%
2013-09-30	-	100.00%
2013-06-30	-	100.00%
2013-03-31	-	100.00%
2012-12-31	-	100.00%
2012-09-30	-	100.00%
2012-06-30	-	100.00%
2012-03-31	-	100.00%
2011-12-31	-	100.00%
2011-09-30	-	100.00%
2011-06-30	-	100.00%
2011-03-31	-	-

Verastem generated $11.24M in revenue during Q3 2025, up 426.06% compared to the previous quarter, and up 112.42% compared to the same period a year ago.

Verastem Revenue Breakdown

Verastem Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 22	Dec 21	Dec 20	Dec 19
Government rebates and other incentives	$4.39M	$67.00K	-	-	-
Returns	$376.00K	$31.00K	-	-	-
Trade discounts and allowances	$888.00K	$23.00K	-	-	-
Sale of COPIKTRA license and related assets	-	$2.60M	-	-	-
Copiktra license and related assets	-	-	$1.45M	-	-
Product Revenue And Allowances Returns	-	-	-	$31.00K	$76.00K
Product Revenue Reserves And Allowances Third Party Payer Chargebacks Discounts And Fees	-	-	-	$2.08M	$255.00K
Product Revenue Reserves And Allowances Trade Discounts And Allowances	-	-	-	$23.00K	$111.00K
Product Revenue Reserves And Allowances Government Rebates And Other Incentives	-	-	-	$67.00K	$372.00K

Verastem's latest annual revenue breakdown by segment (product or service), as of Dec 25: Government rebates and other incentives (77.65%), Trade discounts and allowances (15.70%), and Returns (6.65%).

Quarterly Revenue by Product

Product/Service	Dec 25	Sep 25	Jun 25	Dec 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18
Government rebates and other incentives	$2.02M	$2.04M	$338.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Returns	$185.00K	$165.00K	$26.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Trade discounts and allowances	$392.00K	$467.00K	$29.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sale of COPIKTRA license and related assets	-	-	-	-	$2.60M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Copiktra license and related assets	-	-	-	-	-	$545.00K	-	-	-	-	-	-	-	-	-	-	-	-	-
Transition Services Revenue	-	-	-	-	-	-	$2.00K	-	-	-	-	-	-	-	-	-	-	-	-
Copiktra License And Related Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product Revenue And Allowances Returns	-	-	-	-	-	-	-	$28.00K	$28.00K	$25.00K	$126.00K	$326.00K	$123.00K	$5.00K	$71.00K	$8.00K	$4.00K	$1.00K	$1.00K
Product Revenue Reserves And Allowances Government Rebates And Other Incentives	-	-	-	-	-	-	-	-	$67.00K	$189.00K	$320.00K	$455.00K	$950.00K	$544.00K	$217.00K	$199.00K	$282.00K	$128.00K	$29.00K
Product Revenue Reserves And Allowances Trade Discounts And Allowances	-	-	-	-	-	-	-	$4.00K	$4.00K	$138.00K	$147.00K	$94.00K	$137.00K	$695.00K	$122.00K	$52.00K	$43.00K	$42.00K	$27.00K
Product Revenue Reserves And Allowances Third Party Payer Chargebacks Discounts And Fees	-	-	-	-	-	-	-	-	-	$270.00K	$296.00K	$135.00K	$239.00K	$1.85M	$281.00K	$153.00K	$104.00K	$48.00K	$72.00K

Verastem's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Government rebates and other incentives (77.77%), Trade discounts and allowances (15.10%), and Returns (7.13%).

Verastem Revenue Breakdown by Country

Quarterly Revenue by Country

Country	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18
Sale of COPIKTRA license and related assets	$2.60M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Copiktra license and related assets	-	$545.00K	-	-	-	-	-	-	-	-	-	-	-	-	-
Transition Services Revenue	-	-	$2.00K	-	-	-	-	-	-	-	-	-	-	-	-
Copiktra License And Related Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product Revenue Reserves And Allowances Government Rebates And Other Incentives	-	-	-	-	$67.00K	$189.00K	$320.00K	$455.00K	$950.00K	$544.00K	$217.00K	$199.00K	$282.00K	$128.00K	$29.00K
Product Revenue And Allowances Returns	-	-	-	$28.00K	$28.00K	$25.00K	$126.00K	$326.00K	$123.00K	$5.00K	$71.00K	$8.00K	$4.00K	$1.00K	$1.00K
Product Revenue Reserves And Allowances Trade Discounts And Allowances	-	-	-	$4.00K	$4.00K	$138.00K	$147.00K	$94.00K	$137.00K	$695.00K	$122.00K	$52.00K	$43.00K	$42.00K	$27.00K
Product Revenue Reserves And Allowances Third Party Payer Chargebacks Discounts And Fees	-	-	-	-	-	$270.00K	$296.00K	$135.00K	$239.00K	$1.85M	$281.00K	$153.00K	$104.00K	$48.00K	$72.00K

Verastem's latest quarterly revenue breakdown by geography, as of Mar 22: Sale of COPIKTRA license and related assets (100.00%).

Verastem Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
RGNX	REGENXBIO	$170.44M	$29.73M
GOSS	Gossamer Bio	$48.47M	$13.29M
VSTM	Verastem	$30.91M	$11.24M
PRTA	Prothena	$9.68M	$2.42M
ABSI	Absci	$2.80M	$378.00K
CRVS	Corvus Pharmaceuticals	-	-
VTYX	Ventyx Biosciences	-	-
FDMT	4D Molecular Therapeutics	-	-
KALV	KalVista Pharmaceuticals	-	$13.69M
MLTX	MoonLake Immunotherapeutics	-	-
OLMA	Olema Pharmaceuticals	-	-

VSTM Revenue FAQ

What is Verastem’s yearly revenue?

Verastem's yearly revenue for 2025 was $30.91M, representing an increase of 209.14% compared to 2024. The company's yearly revenue for 2024 was $10M, representing an increase of 100.00% compared to 2023. VSTM's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022.

What is Verastem’s quarterly revenue?

Verastem's quarterly revenue for Q3 2025 was $11.24M, a 426.06% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $2.14M, a 100.00% increase from the previous quarter (Q1 2025), and a -78.63% decrease year-over-year (Q2 2024). VSTM's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Verastem’s revenue growth rate?

Verastem's revenue growth rate for the last 3 years (2023-2025) was 0%, and for the last 5 years (2021-2025) was 1405.80%.

What are Verastem’s revenue streams?

Verastem's revenue streams in c 25 are Government rebates and other incentives, Returns, and Trade discounts and allowances. Government rebates and other incentives generated $4.39M in revenue, accounting 77.65% of the company's total revenue, up 6455.22% year-over-year. Returns generated $376K in revenue, accounting 6.65% of the company's total revenue, up 1112.90% year-over-year. Trade discounts and allowances generated $888K in revenue, accounting 15.70% of the company's total revenue, up 3760.87% year-over-year.

What is Verastem’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Verastem was Government rebates and other incentives. This segment made a revenue of $4.39M, representing 77.65% of the company's total revenue.